Keywords: fidia, gm1, parkinsonism, italian, company, ganglioside, compound

FIDIA'S GM1 AND PARKINSONISM

Article | 11 May 1992

Italian company Fidia's ganglioside compound GM1 may be effective in treating and reversing the degeneration of neurons in Parkinson's disease, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in